Vojta Therapy in Multiple Sclerosis.
The Implementation of a Reflex Locomotion Program According to Vojta Produces Short-term Automatic Postural Control Changes in Patients With Multiple Sclerosis.
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Vojta Therapy
Compared with
- Standard Program
What it measured
Main measures
Berg Balance Scale
2 weeks
Walking and mobility10 metres walk
2 weeks
Walking and mobility
Other measures (1)
Tandem 6 metres test
2 weeks
Walking and mobility
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Final diagnosis of MS according to McDonald criteria. * Walkability with or without assistance (4.0 to 6.5 in EDSS) and dysfunctions defined by the inability to hold the tandem position for 30 seconds with the arms close to body. * Older than 18 years-old. * Escorted sessions, a family member or close person.
Exclusion criteria
* Phase outbreak or outbreak in the 3 months before the study. * Medication that prevents or limits the performance of the Locomotion reflex. * Participation in other studies during the conduct of this study. * Score inferior to 6 in the Abbreviated Mental Test that prevents understanding of the study consent or that limits the understanding of the test during its realisation.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This Study evaluates the effectiveness of a Vojta locomotion reflex program as short-term automatic postural control in patients with Multiple sclerosis
Papers
Loading reviews and guidelines…
History
Started
Jan 2019
Main results due
Mar 2019
Finished
May 2019